pI: 5.2546 |
Length (AA): 239 |
MW (Da): 25341 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 238 | 3qdf (A) | 27 | 264 | 95.00 | 0 | 1 | 2.09882 | -1.09 |
2 | 236 | 3rr6 (A) | 28 | 259 | 81.00 | 0 | 1 | 1.96796 | -1.13 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Dormant phase. | hasan |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | Dormant phase. | murphy |
hasan | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. |
murphy | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. |
Ortholog group members (OG5_126763)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G15940 | fumarylacetoacetate hydrolase-like protein |
Brugia malayi | Bm1_36665 | fumarylacetoacetate hydrolase domain containing 1, putative |
Candida albicans | CaO19.9730 | one of two fumarylacetoacetate hydrolase family genes |
Candida albicans | CaO19.2184 | one of two fumarylacetoacetate hydrolase family genes |
Candida albicans | CaO19.7244 | one of two fumarylacetoacetate hydrolase family genes |
Caenorhabditis elegans | CELE_ZK688.3 | Protein FAHD-1 |
Dictyostelium discoideum | DDB_G0275071 | Fumarylacetoacetate hydrolase domain-containing protein |
Dictyostelium discoideum | DDB_G0293650 | Fumarylacetoacetate hydrolase domain-containing protein |
Drosophila melanogaster | Dmel_CG6028 | CG6028 gene product from transcript CG6028-RA |
Drosophila melanogaster | Dmel_CG5793 | CG5793 gene product from transcript CG5793-RE |
Escherichia coli | b1180 | putative isomerase/hydrolase |
Homo sapiens | ENSG00000180185 | fumarylacetoacetate hydrolase domain containing 1 |
Homo sapiens | ENSG00000115042 | fumarylacetoacetate hydrolase domain containing 2A |
Homo sapiens | ENSG00000144199 | fumarylacetoacetate hydrolase domain containing 2B |
Leishmania braziliensis | LbrM.34.2390 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_352490.1 | Fumarylacetoacetate (FAA) hydrolase family, putative |
Leishmania infantum | LinJ.35.2490 | hypothetical protein, conserved |
Leishmania major | LmjF.35.2440 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.34.2440 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_09728 | fumarylacetoacetate hydrolase domain containing 1 |
Mycobacterium leprae | ML1689c | POSSIBLE 2-HYDROXYHEPTA-2,4-DIENE-1,7-DIOATE ISOMERASE (HHDD ISOMERASE) |
Mus musculus | ENSMUSG00000045316 | fumarylacetoacetate hydrolase domain containing 1 |
Mus musculus | ENSMUSG00000027371 | fumarylacetoacetate hydrolase domain containing 2A |
Mycobacterium tuberculosis | Rv2993c | Possible 2-hydroxyhepta-2,4-diene-1,7-dioate isomerase (HHDD isomerase) |
Mycobacterium ulcerans | MUL_1956 | 2-hydroxyhepta-2,4-diene-1,7-dioate isomerase |
Oryza sativa | 4334655 | Os03g0829000 |
Oryza sativa | 9266575 | Os03g0421700 |
Oryza sativa | 4333132 | Os03g0421500 |
Saccharomyces cerevisiae | YNL168C | Fmp41p |
Schistosoma japonicum | Sjp_0002630 | ko:K01826 5-carboxymethyl-2-hydroxymuconate isomerase [EC5.3.3.10], putative |
Schistosoma mansoni | Smp_175750 | fumarylacetoacetate hydrolase |
Schmidtea mediterranea | mk4.004541.01 | Fumarylacetoacetate hydrolase, putative |
Schmidtea mediterranea | mk4.007878.00 | Fumarylacetoacetate hydrolase, putative |
Trypanosoma cruzi | TcCLB.510749.10 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.510657.50 | hypothetical protein, conserved |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
b1180 | Escherichia coli | non-essential | goodall |
CELE_ZK688.3 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_ZK688.3 | Caenorhabditis elegans | larval arrest | wormbase |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.2
1 literature reference was collected for this gene.